nodes	percent_of_prediction	percent_of_DWPC	metapath
Clarithromycin—Cytochrome P450 3A Inhibitors—Saquinavir—acquired immunodeficiency syndrome	0.163	0.258	CiPCiCtD
Clarithromycin—Cytochrome P450 3A Inhibitors—Lopinavir—acquired immunodeficiency syndrome	0.123	0.196	CiPCiCtD
Clarithromycin—P-Glycoprotein Inhibitors—Lopinavir—acquired immunodeficiency syndrome	0.077	0.122	CiPCiCtD
Clarithromycin—Cytochrome P450 3A Inhibitors—Ritonavir—acquired immunodeficiency syndrome	0.0746	0.119	CiPCiCtD
Clarithromycin—Cytochrome P450 3A4 Inhibitors—Amprenavir—acquired immunodeficiency syndrome	0.0602	0.0955	CiPCiCtD
Clarithromycin—P-Glycoprotein Inhibitors—Ritonavir—acquired immunodeficiency syndrome	0.0466	0.0741	CiPCiCtD
Clarithromycin—Cytochrome P450 3A4 Inhibitors—Efavirenz—acquired immunodeficiency syndrome	0.0429	0.0681	CiPCiCtD
Clarithromycin—Cytochrome P450 3A4 Inhibitors—Ritonavir—acquired immunodeficiency syndrome	0.0429	0.0681	CiPCiCtD
Clarithromycin—SLC22A7—Zidovudine—acquired immunodeficiency syndrome	0.0181	0.0638	CbGbCtD
Clarithromycin—CYP3A7-CYP3A51P—Delavirdine—acquired immunodeficiency syndrome	0.00969	0.0341	CbGbCtD
Clarithromycin—CYP3A7—Delavirdine—acquired immunodeficiency syndrome	0.00969	0.0341	CbGbCtD
Clarithromycin—CYP3A7-CYP3A51P—Indinavir—acquired immunodeficiency syndrome	0.00836	0.0294	CbGbCtD
Clarithromycin—CYP3A7—Indinavir—acquired immunodeficiency syndrome	0.00836	0.0294	CbGbCtD
Clarithromycin—CYP3A7—Nelfinavir—acquired immunodeficiency syndrome	0.00812	0.0286	CbGbCtD
Clarithromycin—CYP3A7-CYP3A51P—Nelfinavir—acquired immunodeficiency syndrome	0.00812	0.0286	CbGbCtD
Clarithromycin—CYP3A5—Nevirapine—acquired immunodeficiency syndrome	0.00804	0.0283	CbGbCtD
Clarithromycin—CYP3A7-CYP3A51P—Ritonavir—acquired immunodeficiency syndrome	0.00734	0.0258	CbGbCtD
Clarithromycin—CYP3A7-CYP3A51P—Saquinavir—acquired immunodeficiency syndrome	0.00734	0.0258	CbGbCtD
Clarithromycin—CYP3A7—Ritonavir—acquired immunodeficiency syndrome	0.00734	0.0258	CbGbCtD
Clarithromycin—CYP3A7—Saquinavir—acquired immunodeficiency syndrome	0.00734	0.0258	CbGbCtD
Clarithromycin—CYP3A5—Delavirdine—acquired immunodeficiency syndrome	0.00727	0.0256	CbGbCtD
Clarithromycin—CYP3A5—Amprenavir—acquired immunodeficiency syndrome	0.00727	0.0256	CbGbCtD
Clarithromycin—CYP2C19—Efavirenz—acquired immunodeficiency syndrome	0.00689	0.0243	CbGbCtD
Clarithromycin—CYP2C19—Lopinavir—acquired immunodeficiency syndrome	0.00648	0.0228	CbGbCtD
Clarithromycin—CYP1A2—Efavirenz—acquired immunodeficiency syndrome	0.00636	0.0224	CbGbCtD
Clarithromycin—CYP3A5—Indinavir—acquired immunodeficiency syndrome	0.00627	0.0221	CbGbCtD
Clarithromycin—CYP3A5—Nelfinavir—acquired immunodeficiency syndrome	0.00609	0.0214	CbGbCtD
Clarithromycin—CYP1A2—Lopinavir—acquired immunodeficiency syndrome	0.00598	0.0211	CbGbCtD
Clarithromycin—CYP1A2—Nevirapine—acquired immunodeficiency syndrome	0.00598	0.0211	CbGbCtD
Clarithromycin—CYP2C19—Amprenavir—acquired immunodeficiency syndrome	0.00586	0.0206	CbGbCtD
Clarithromycin—CYP2C19—Delavirdine—acquired immunodeficiency syndrome	0.00586	0.0206	CbGbCtD
Clarithromycin—CYP3A5—Ritonavir—acquired immunodeficiency syndrome	0.00551	0.0194	CbGbCtD
Clarithromycin—CYP3A5—Saquinavir—acquired immunodeficiency syndrome	0.00551	0.0194	CbGbCtD
Clarithromycin—CYP1A2—Delavirdine—acquired immunodeficiency syndrome	0.00541	0.019	CbGbCtD
Clarithromycin—ABCB1—Lopinavir—acquired immunodeficiency syndrome	0.00523	0.0184	CbGbCtD
Clarithromycin—CYP2C19—Indinavir—acquired immunodeficiency syndrome	0.00506	0.0178	CbGbCtD
Clarithromycin—CYP2C19—Nelfinavir—acquired immunodeficiency syndrome	0.00491	0.0173	CbGbCtD
Clarithromycin—ABCB1—Amprenavir—acquired immunodeficiency syndrome	0.00473	0.0166	CbGbCtD
Clarithromycin—CYP1A2—Nelfinavir—acquired immunodeficiency syndrome	0.00453	0.016	CbGbCtD
Clarithromycin—CYP2C19—Saquinavir—acquired immunodeficiency syndrome	0.00444	0.0156	CbGbCtD
Clarithromycin—CYP2C19—Ritonavir—acquired immunodeficiency syndrome	0.00444	0.0156	CbGbCtD
Clarithromycin—CYP2C19—Zidovudine—acquired immunodeficiency syndrome	0.00426	0.015	CbGbCtD
Clarithromycin—CYP1A2—Ritonavir—acquired immunodeficiency syndrome	0.0041	0.0144	CbGbCtD
Clarithromycin—ABCB1—Indinavir—acquired immunodeficiency syndrome	0.00408	0.0144	CbGbCtD
Clarithromycin—ABCB1—Nelfinavir—acquired immunodeficiency syndrome	0.00396	0.014	CbGbCtD
Clarithromycin—ABCB1—Ritonavir—acquired immunodeficiency syndrome	0.00358	0.0126	CbGbCtD
Clarithromycin—ABCB1—Saquinavir—acquired immunodeficiency syndrome	0.00358	0.0126	CbGbCtD
Clarithromycin—ABCB1—Zidovudine—acquired immunodeficiency syndrome	0.00344	0.0121	CbGbCtD
Clarithromycin—CYP3A4—Efavirenz—acquired immunodeficiency syndrome	0.00333	0.0117	CbGbCtD
Clarithromycin—CYP3A4—Nevirapine—acquired immunodeficiency syndrome	0.00313	0.011	CbGbCtD
Clarithromycin—CYP3A4—Lopinavir—acquired immunodeficiency syndrome	0.00313	0.011	CbGbCtD
Clarithromycin—CYP3A4—Delavirdine—acquired immunodeficiency syndrome	0.00283	0.00997	CbGbCtD
Clarithromycin—CYP3A4—Amprenavir—acquired immunodeficiency syndrome	0.00283	0.00997	CbGbCtD
Clarithromycin—ABCB1—Lamivudine—acquired immunodeficiency syndrome	0.00266	0.00936	CbGbCtD
Clarithromycin—CYP3A4—Indinavir—acquired immunodeficiency syndrome	0.00245	0.00861	CbGbCtD
Clarithromycin—CYP3A4—Nelfinavir—acquired immunodeficiency syndrome	0.00237	0.00836	CbGbCtD
Clarithromycin—CYP3A4—Ritonavir—acquired immunodeficiency syndrome	0.00215	0.00756	CbGbCtD
Clarithromycin—CYP3A4—Saquinavir—acquired immunodeficiency syndrome	0.00215	0.00756	CbGbCtD
Clarithromycin—CYP3A4—Zidovudine—acquired immunodeficiency syndrome	0.00206	0.00725	CbGbCtD
Clarithromycin—CYP2C19—blood plasma—acquired immunodeficiency syndrome	7.57e-05	0.0957	CbGeAlD
Clarithromycin—CYP1A2—blood plasma—acquired immunodeficiency syndrome	6.18e-05	0.0781	CbGeAlD
Clarithromycin—SLC22A7—digestive system—acquired immunodeficiency syndrome	6e-05	0.0759	CbGeAlD
Clarithromycin—CYP3A5—blood plasma—acquired immunodeficiency syndrome	5.96e-05	0.0754	CbGeAlD
Clarithromycin—CYP3A4—blood plasma—acquired immunodeficiency syndrome	4.47e-05	0.0566	CbGeAlD
Clarithromycin—Dyspepsia—Indinavir—acquired immunodeficiency syndrome	3.79e-05	0.000444	CcSEcCtD
Clarithromycin—Gastrointestinal pain—Zidovudine—acquired immunodeficiency syndrome	3.79e-05	0.000443	CcSEcCtD
Clarithromycin—Skin disorder—Delavirdine—acquired immunodeficiency syndrome	3.78e-05	0.000443	CcSEcCtD
Clarithromycin—Pruritus—Nelfinavir—acquired immunodeficiency syndrome	3.78e-05	0.000443	CcSEcCtD
Clarithromycin—Diarrhoea—Nevirapine—acquired immunodeficiency syndrome	3.77e-05	0.000442	CcSEcCtD
Clarithromycin—Pruritus—Stavudine—acquired immunodeficiency syndrome	3.77e-05	0.000441	CcSEcCtD
Clarithromycin—Asthenia—Abacavir—acquired immunodeficiency syndrome	3.77e-05	0.000441	CcSEcCtD
Clarithromycin—Hyperhidrosis—Delavirdine—acquired immunodeficiency syndrome	3.76e-05	0.000441	CcSEcCtD
Clarithromycin—Ill-defined disorder—Lamivudine—acquired immunodeficiency syndrome	3.76e-05	0.00044	CcSEcCtD
Clarithromycin—Chest pain—Ritonavir—acquired immunodeficiency syndrome	3.75e-05	0.00044	CcSEcCtD
Clarithromycin—Myalgia—Ritonavir—acquired immunodeficiency syndrome	3.75e-05	0.00044	CcSEcCtD
Clarithromycin—Decreased appetite—Indinavir—acquired immunodeficiency syndrome	3.74e-05	0.000438	CcSEcCtD
Clarithromycin—Anaemia—Lamivudine—acquired immunodeficiency syndrome	3.74e-05	0.000438	CcSEcCtD
Clarithromycin—Anxiety—Ritonavir—acquired immunodeficiency syndrome	3.74e-05	0.000438	CcSEcCtD
Clarithromycin—Loss of consciousness—Saquinavir—acquired immunodeficiency syndrome	3.73e-05	0.000437	CcSEcCtD
Clarithromycin—Unspecified disorder of skin and subcutaneous tissue—Ritonavir—acquired immunodeficiency syndrome	3.73e-05	0.000437	CcSEcCtD
Clarithromycin—Gastrointestinal disorder—Indinavir—acquired immunodeficiency syndrome	3.72e-05	0.000435	CcSEcCtD
Clarithromycin—Pruritus—Abacavir—acquired immunodeficiency syndrome	3.71e-05	0.000435	CcSEcCtD
Clarithromycin—Fatigue—Indinavir—acquired immunodeficiency syndrome	3.71e-05	0.000435	CcSEcCtD
Clarithromycin—Anorexia—Delavirdine—acquired immunodeficiency syndrome	3.71e-05	0.000435	CcSEcCtD
Clarithromycin—Discomfort—Ritonavir—acquired immunodeficiency syndrome	3.71e-05	0.000434	CcSEcCtD
Clarithromycin—Musculoskeletal discomfort—Efavirenz—acquired immunodeficiency syndrome	3.71e-05	0.000434	CcSEcCtD
Clarithromycin—Cough—Saquinavir—acquired immunodeficiency syndrome	3.7e-05	0.000434	CcSEcCtD
Clarithromycin—Angioedema—Lamivudine—acquired immunodeficiency syndrome	3.7e-05	0.000433	CcSEcCtD
Clarithromycin—Pain—Indinavir—acquired immunodeficiency syndrome	3.68e-05	0.000431	CcSEcCtD
Clarithromycin—Constipation—Indinavir—acquired immunodeficiency syndrome	3.68e-05	0.000431	CcSEcCtD
Clarithromycin—Insomnia—Efavirenz—acquired immunodeficiency syndrome	3.68e-05	0.000431	CcSEcCtD
Clarithromycin—Urticaria—Zidovudine—acquired immunodeficiency syndrome	3.68e-05	0.000431	CcSEcCtD
Clarithromycin—Convulsion—Saquinavir—acquired immunodeficiency syndrome	3.68e-05	0.000431	CcSEcCtD
Clarithromycin—Dry mouth—Ritonavir—acquired immunodeficiency syndrome	3.67e-05	0.00043	CcSEcCtD
Clarithromycin—Abdominal pain—Zidovudine—acquired immunodeficiency syndrome	3.66e-05	0.000429	CcSEcCtD
Clarithromycin—Body temperature increased—Zidovudine—acquired immunodeficiency syndrome	3.66e-05	0.000429	CcSEcCtD
Clarithromycin—Diarrhoea—Nelfinavir—acquired immunodeficiency syndrome	3.66e-05	0.000428	CcSEcCtD
Clarithromycin—Paraesthesia—Efavirenz—acquired immunodeficiency syndrome	3.65e-05	0.000428	CcSEcCtD
Clarithromycin—Malaise—Lamivudine—acquired immunodeficiency syndrome	3.65e-05	0.000428	CcSEcCtD
Clarithromycin—Diarrhoea—Stavudine—acquired immunodeficiency syndrome	3.64e-05	0.000427	CcSEcCtD
Clarithromycin—Nausea—Didanosine—acquired immunodeficiency syndrome	3.64e-05	0.000427	CcSEcCtD
Clarithromycin—Vertigo—Lamivudine—acquired immunodeficiency syndrome	3.64e-05	0.000426	CcSEcCtD
Clarithromycin—Confusional state—Ritonavir—acquired immunodeficiency syndrome	3.63e-05	0.000425	CcSEcCtD
Clarithromycin—Dyspnoea—Efavirenz—acquired immunodeficiency syndrome	3.63e-05	0.000425	CcSEcCtD
Clarithromycin—Leukopenia—Lamivudine—acquired immunodeficiency syndrome	3.63e-05	0.000425	CcSEcCtD
Clarithromycin—Somnolence—Efavirenz—acquired immunodeficiency syndrome	3.62e-05	0.000424	CcSEcCtD
Clarithromycin—Chest pain—Saquinavir—acquired immunodeficiency syndrome	3.61e-05	0.000423	CcSEcCtD
Clarithromycin—Myalgia—Saquinavir—acquired immunodeficiency syndrome	3.61e-05	0.000423	CcSEcCtD
Clarithromycin—Anxiety—Saquinavir—acquired immunodeficiency syndrome	3.6e-05	0.000422	CcSEcCtD
Clarithromycin—Diarrhoea—Abacavir—acquired immunodeficiency syndrome	3.59e-05	0.00042	CcSEcCtD
Clarithromycin—Unspecified disorder of skin and subcutaneous tissue—Saquinavir—acquired immunodeficiency syndrome	3.59e-05	0.00042	CcSEcCtD
Clarithromycin—Dyspepsia—Efavirenz—acquired immunodeficiency syndrome	3.58e-05	0.000419	CcSEcCtD
Clarithromycin—Discomfort—Saquinavir—acquired immunodeficiency syndrome	3.57e-05	0.000418	CcSEcCtD
Clarithromycin—Loss of consciousness—Lamivudine—acquired immunodeficiency syndrome	3.56e-05	0.000417	CcSEcCtD
Clarithromycin—SLC22A7—brain—acquired immunodeficiency syndrome	3.55e-05	0.0449	CbGeAlD
Clarithromycin—Feeling abnormal—Indinavir—acquired immunodeficiency syndrome	3.55e-05	0.000416	CcSEcCtD
Clarithromycin—Musculoskeletal discomfort—Delavirdine—acquired immunodeficiency syndrome	3.55e-05	0.000415	CcSEcCtD
Clarithromycin—Decreased appetite—Efavirenz—acquired immunodeficiency syndrome	3.54e-05	0.000414	CcSEcCtD
Clarithromycin—Dry mouth—Saquinavir—acquired immunodeficiency syndrome	3.53e-05	0.000414	CcSEcCtD
Clarithromycin—Cough—Lamivudine—acquired immunodeficiency syndrome	3.53e-05	0.000414	CcSEcCtD
Clarithromycin—Dizziness—Nelfinavir—acquired immunodeficiency syndrome	3.53e-05	0.000414	CcSEcCtD
Clarithromycin—Nervous system disorder—Ritonavir—acquired immunodeficiency syndrome	3.53e-05	0.000413	CcSEcCtD
Clarithromycin—Thrombocytopenia—Ritonavir—acquired immunodeficiency syndrome	3.52e-05	0.000413	CcSEcCtD
Clarithromycin—Dizziness—Stavudine—acquired immunodeficiency syndrome	3.52e-05	0.000413	CcSEcCtD
Clarithromycin—Gastrointestinal pain—Indinavir—acquired immunodeficiency syndrome	3.52e-05	0.000412	CcSEcCtD
Clarithromycin—Insomnia—Delavirdine—acquired immunodeficiency syndrome	3.52e-05	0.000412	CcSEcCtD
Clarithromycin—Gastrointestinal disorder—Efavirenz—acquired immunodeficiency syndrome	3.51e-05	0.000411	CcSEcCtD
Clarithromycin—Convulsion—Lamivudine—acquired immunodeficiency syndrome	3.51e-05	0.000411	CcSEcCtD
Clarithromycin—Vomiting—Nevirapine—acquired immunodeficiency syndrome	3.51e-05	0.000411	CcSEcCtD
Clarithromycin—Fatigue—Efavirenz—acquired immunodeficiency syndrome	3.51e-05	0.000411	CcSEcCtD
Clarithromycin—Skin disorder—Ritonavir—acquired immunodeficiency syndrome	3.5e-05	0.000409	CcSEcCtD
Clarithromycin—Paraesthesia—Delavirdine—acquired immunodeficiency syndrome	3.5e-05	0.000409	CcSEcCtD
Clarithromycin—Confusional state—Saquinavir—acquired immunodeficiency syndrome	3.49e-05	0.000409	CcSEcCtD
Clarithromycin—Hyperhidrosis—Ritonavir—acquired immunodeficiency syndrome	3.48e-05	0.000408	CcSEcCtD
Clarithromycin—Pain—Efavirenz—acquired immunodeficiency syndrome	3.48e-05	0.000407	CcSEcCtD
Clarithromycin—Constipation—Efavirenz—acquired immunodeficiency syndrome	3.48e-05	0.000407	CcSEcCtD
Clarithromycin—Rash—Nevirapine—acquired immunodeficiency syndrome	3.48e-05	0.000407	CcSEcCtD
Clarithromycin—Dermatitis—Nevirapine—acquired immunodeficiency syndrome	3.48e-05	0.000407	CcSEcCtD
Clarithromycin—Dyspnoea—Delavirdine—acquired immunodeficiency syndrome	3.47e-05	0.000406	CcSEcCtD
Clarithromycin—Dizziness—Abacavir—acquired immunodeficiency syndrome	3.47e-05	0.000406	CcSEcCtD
Clarithromycin—Somnolence—Delavirdine—acquired immunodeficiency syndrome	3.46e-05	0.000405	CcSEcCtD
Clarithromycin—Headache—Nevirapine—acquired immunodeficiency syndrome	3.46e-05	0.000405	CcSEcCtD
Clarithromycin—Chest pain—Lamivudine—acquired immunodeficiency syndrome	3.45e-05	0.000404	CcSEcCtD
Clarithromycin—Myalgia—Lamivudine—acquired immunodeficiency syndrome	3.45e-05	0.000404	CcSEcCtD
Clarithromycin—Infection—Saquinavir—acquired immunodeficiency syndrome	3.44e-05	0.000403	CcSEcCtD
Clarithromycin—Anxiety—Lamivudine—acquired immunodeficiency syndrome	3.44e-05	0.000402	CcSEcCtD
Clarithromycin—Anorexia—Ritonavir—acquired immunodeficiency syndrome	3.43e-05	0.000402	CcSEcCtD
Clarithromycin—Dyspepsia—Delavirdine—acquired immunodeficiency syndrome	3.43e-05	0.000401	CcSEcCtD
Clarithromycin—Unspecified disorder of skin and subcutaneous tissue—Lamivudine—acquired immunodeficiency syndrome	3.42e-05	0.000401	CcSEcCtD
Clarithromycin—Urticaria—Indinavir—acquired immunodeficiency syndrome	3.42e-05	0.000401	CcSEcCtD
Clarithromycin—Discomfort—Lamivudine—acquired immunodeficiency syndrome	3.41e-05	0.000399	CcSEcCtD
Clarithromycin—Abdominal pain—Indinavir—acquired immunodeficiency syndrome	3.4e-05	0.000399	CcSEcCtD
Clarithromycin—Body temperature increased—Indinavir—acquired immunodeficiency syndrome	3.4e-05	0.000399	CcSEcCtD
Clarithromycin—Nervous system disorder—Saquinavir—acquired immunodeficiency syndrome	3.4e-05	0.000398	CcSEcCtD
Clarithromycin—Vomiting—Nelfinavir—acquired immunodeficiency syndrome	3.4e-05	0.000398	CcSEcCtD
Clarithromycin—Thrombocytopenia—Saquinavir—acquired immunodeficiency syndrome	3.39e-05	0.000397	CcSEcCtD
Clarithromycin—Vomiting—Stavudine—acquired immunodeficiency syndrome	3.39e-05	0.000397	CcSEcCtD
Clarithromycin—Decreased appetite—Delavirdine—acquired immunodeficiency syndrome	3.38e-05	0.000396	CcSEcCtD
Clarithromycin—Dry mouth—Lamivudine—acquired immunodeficiency syndrome	3.37e-05	0.000395	CcSEcCtD
Clarithromycin—Rash—Nelfinavir—acquired immunodeficiency syndrome	3.37e-05	0.000395	CcSEcCtD
Clarithromycin—Dermatitis—Nelfinavir—acquired immunodeficiency syndrome	3.37e-05	0.000394	CcSEcCtD
Clarithromycin—Skin disorder—Saquinavir—acquired immunodeficiency syndrome	3.37e-05	0.000394	CcSEcCtD
Clarithromycin—Gastrointestinal disorder—Delavirdine—acquired immunodeficiency syndrome	3.36e-05	0.000394	CcSEcCtD
Clarithromycin—Rash—Stavudine—acquired immunodeficiency syndrome	3.36e-05	0.000393	CcSEcCtD
Clarithromycin—Fatigue—Delavirdine—acquired immunodeficiency syndrome	3.36e-05	0.000393	CcSEcCtD
Clarithromycin—Dermatitis—Stavudine—acquired immunodeficiency syndrome	3.36e-05	0.000393	CcSEcCtD
Clarithromycin—Feeling abnormal—Efavirenz—acquired immunodeficiency syndrome	3.35e-05	0.000393	CcSEcCtD
Clarithromycin—Hyperhidrosis—Saquinavir—acquired immunodeficiency syndrome	3.35e-05	0.000392	CcSEcCtD
Clarithromycin—Headache—Nelfinavir—acquired immunodeficiency syndrome	3.35e-05	0.000392	CcSEcCtD
Clarithromycin—Headache—Stavudine—acquired immunodeficiency syndrome	3.34e-05	0.000391	CcSEcCtD
Clarithromycin—Vomiting—Abacavir—acquired immunodeficiency syndrome	3.34e-05	0.000391	CcSEcCtD
Clarithromycin—Confusional state—Lamivudine—acquired immunodeficiency syndrome	3.33e-05	0.00039	CcSEcCtD
Clarithromycin—Constipation—Delavirdine—acquired immunodeficiency syndrome	3.33e-05	0.00039	CcSEcCtD
Clarithromycin—Pain—Delavirdine—acquired immunodeficiency syndrome	3.33e-05	0.00039	CcSEcCtD
Clarithromycin—Gastrointestinal pain—Efavirenz—acquired immunodeficiency syndrome	3.33e-05	0.00039	CcSEcCtD
Clarithromycin—Asthenia—Zidovudine—acquired immunodeficiency syndrome	3.32e-05	0.000389	CcSEcCtD
Clarithromycin—Rash—Abacavir—acquired immunodeficiency syndrome	3.31e-05	0.000387	CcSEcCtD
Clarithromycin—Dermatitis—Abacavir—acquired immunodeficiency syndrome	3.31e-05	0.000387	CcSEcCtD
Clarithromycin—Anaphylactic shock—Lamivudine—acquired immunodeficiency syndrome	3.31e-05	0.000387	CcSEcCtD
Clarithromycin—Anorexia—Saquinavir—acquired immunodeficiency syndrome	3.3e-05	0.000387	CcSEcCtD
Clarithromycin—Headache—Abacavir—acquired immunodeficiency syndrome	3.29e-05	0.000385	CcSEcCtD
Clarithromycin—Infection—Lamivudine—acquired immunodeficiency syndrome	3.28e-05	0.000385	CcSEcCtD
Clarithromycin—Musculoskeletal discomfort—Ritonavir—acquired immunodeficiency syndrome	3.28e-05	0.000384	CcSEcCtD
Clarithromycin—Nausea—Nevirapine—acquired immunodeficiency syndrome	3.28e-05	0.000384	CcSEcCtD
Clarithromycin—Pruritus—Zidovudine—acquired immunodeficiency syndrome	3.28e-05	0.000384	CcSEcCtD
Clarithromycin—Insomnia—Ritonavir—acquired immunodeficiency syndrome	3.26e-05	0.000381	CcSEcCtD
Clarithromycin—Nervous system disorder—Lamivudine—acquired immunodeficiency syndrome	3.24e-05	0.00038	CcSEcCtD
Clarithromycin—Thrombocytopenia—Lamivudine—acquired immunodeficiency syndrome	3.24e-05	0.000379	CcSEcCtD
Clarithromycin—Paraesthesia—Ritonavir—acquired immunodeficiency syndrome	3.23e-05	0.000379	CcSEcCtD
Clarithromycin—Urticaria—Efavirenz—acquired immunodeficiency syndrome	3.23e-05	0.000378	CcSEcCtD
Clarithromycin—Body temperature increased—Efavirenz—acquired immunodeficiency syndrome	3.22e-05	0.000377	CcSEcCtD
Clarithromycin—Abdominal pain—Efavirenz—acquired immunodeficiency syndrome	3.22e-05	0.000377	CcSEcCtD
Clarithromycin—Skin disorder—Lamivudine—acquired immunodeficiency syndrome	3.21e-05	0.000376	CcSEcCtD
Clarithromycin—Dyspnoea—Ritonavir—acquired immunodeficiency syndrome	3.21e-05	0.000376	CcSEcCtD
Clarithromycin—Feeling abnormal—Delavirdine—acquired immunodeficiency syndrome	3.21e-05	0.000376	CcSEcCtD
Clarithromycin—Somnolence—Ritonavir—acquired immunodeficiency syndrome	3.2e-05	0.000375	CcSEcCtD
Clarithromycin—Hyperhidrosis—Lamivudine—acquired immunodeficiency syndrome	3.2e-05	0.000374	CcSEcCtD
Clarithromycin—Gastrointestinal pain—Delavirdine—acquired immunodeficiency syndrome	3.18e-05	0.000373	CcSEcCtD
Clarithromycin—Nausea—Nelfinavir—acquired immunodeficiency syndrome	3.17e-05	0.000372	CcSEcCtD
Clarithromycin—Hypersensitivity—Indinavir—acquired immunodeficiency syndrome	3.17e-05	0.000372	CcSEcCtD
Clarithromycin—Dyspepsia—Ritonavir—acquired immunodeficiency syndrome	3.17e-05	0.000371	CcSEcCtD
Clarithromycin—Diarrhoea—Zidovudine—acquired immunodeficiency syndrome	3.17e-05	0.000371	CcSEcCtD
Clarithromycin—ABCB1—blood plasma—acquired immunodeficiency syndrome	3.17e-05	0.04	CbGeAlD
Clarithromycin—Nausea—Stavudine—acquired immunodeficiency syndrome	3.16e-05	0.000371	CcSEcCtD
Clarithromycin—Musculoskeletal discomfort—Saquinavir—acquired immunodeficiency syndrome	3.16e-05	0.00037	CcSEcCtD
Clarithromycin—Anorexia—Lamivudine—acquired immunodeficiency syndrome	3.15e-05	0.000369	CcSEcCtD
Clarithromycin—Insomnia—Saquinavir—acquired immunodeficiency syndrome	3.13e-05	0.000367	CcSEcCtD
Clarithromycin—Decreased appetite—Ritonavir—acquired immunodeficiency syndrome	3.13e-05	0.000366	CcSEcCtD
Clarithromycin—Nausea—Abacavir—acquired immunodeficiency syndrome	3.12e-05	0.000365	CcSEcCtD
Clarithromycin—Paraesthesia—Saquinavir—acquired immunodeficiency syndrome	3.11e-05	0.000364	CcSEcCtD
Clarithromycin—Gastrointestinal disorder—Ritonavir—acquired immunodeficiency syndrome	3.11e-05	0.000364	CcSEcCtD
Clarithromycin—Fatigue—Ritonavir—acquired immunodeficiency syndrome	3.1e-05	0.000363	CcSEcCtD
Clarithromycin—Urticaria—Delavirdine—acquired immunodeficiency syndrome	3.09e-05	0.000362	CcSEcCtD
Clarithromycin—Asthenia—Indinavir—acquired immunodeficiency syndrome	3.09e-05	0.000362	CcSEcCtD
Clarithromycin—Dyspnoea—Saquinavir—acquired immunodeficiency syndrome	3.09e-05	0.000362	CcSEcCtD
Clarithromycin—Somnolence—Saquinavir—acquired immunodeficiency syndrome	3.08e-05	0.000361	CcSEcCtD
Clarithromycin—Pain—Ritonavir—acquired immunodeficiency syndrome	3.08e-05	0.00036	CcSEcCtD
Clarithromycin—Constipation—Ritonavir—acquired immunodeficiency syndrome	3.08e-05	0.00036	CcSEcCtD
Clarithromycin—Body temperature increased—Delavirdine—acquired immunodeficiency syndrome	3.08e-05	0.00036	CcSEcCtD
Clarithromycin—Abdominal pain—Delavirdine—acquired immunodeficiency syndrome	3.08e-05	0.00036	CcSEcCtD
Clarithromycin—Dizziness—Zidovudine—acquired immunodeficiency syndrome	3.06e-05	0.000359	CcSEcCtD
Clarithromycin—Dyspepsia—Saquinavir—acquired immunodeficiency syndrome	3.05e-05	0.000357	CcSEcCtD
Clarithromycin—Pruritus—Indinavir—acquired immunodeficiency syndrome	3.05e-05	0.000357	CcSEcCtD
Clarithromycin—Decreased appetite—Saquinavir—acquired immunodeficiency syndrome	3.01e-05	0.000353	CcSEcCtD
Clarithromycin—Musculoskeletal discomfort—Lamivudine—acquired immunodeficiency syndrome	3.01e-05	0.000353	CcSEcCtD
Clarithromycin—Hypersensitivity—Efavirenz—acquired immunodeficiency syndrome	3e-05	0.000351	CcSEcCtD
Clarithromycin—Gastrointestinal disorder—Saquinavir—acquired immunodeficiency syndrome	2.99e-05	0.00035	CcSEcCtD
Clarithromycin—Insomnia—Lamivudine—acquired immunodeficiency syndrome	2.99e-05	0.00035	CcSEcCtD
Clarithromycin—Fatigue—Saquinavir—acquired immunodeficiency syndrome	2.99e-05	0.00035	CcSEcCtD
Clarithromycin—Paraesthesia—Lamivudine—acquired immunodeficiency syndrome	2.97e-05	0.000348	CcSEcCtD
Clarithromycin—Feeling abnormal—Ritonavir—acquired immunodeficiency syndrome	2.97e-05	0.000347	CcSEcCtD
Clarithromycin—Pain—Saquinavir—acquired immunodeficiency syndrome	2.96e-05	0.000347	CcSEcCtD
Clarithromycin—Constipation—Saquinavir—acquired immunodeficiency syndrome	2.96e-05	0.000347	CcSEcCtD
Clarithromycin—Dyspnoea—Lamivudine—acquired immunodeficiency syndrome	2.95e-05	0.000345	CcSEcCtD
Clarithromycin—Diarrhoea—Indinavir—acquired immunodeficiency syndrome	2.95e-05	0.000345	CcSEcCtD
Clarithromycin—Vomiting—Zidovudine—acquired immunodeficiency syndrome	2.94e-05	0.000345	CcSEcCtD
Clarithromycin—Gastrointestinal pain—Ritonavir—acquired immunodeficiency syndrome	2.94e-05	0.000345	CcSEcCtD
Clarithromycin—Somnolence—Lamivudine—acquired immunodeficiency syndrome	2.94e-05	0.000344	CcSEcCtD
Clarithromycin—Rash—Zidovudine—acquired immunodeficiency syndrome	2.92e-05	0.000342	CcSEcCtD
Clarithromycin—Asthenia—Efavirenz—acquired immunodeficiency syndrome	2.92e-05	0.000342	CcSEcCtD
Clarithromycin—Dermatitis—Zidovudine—acquired immunodeficiency syndrome	2.92e-05	0.000342	CcSEcCtD
Clarithromycin—Dyspepsia—Lamivudine—acquired immunodeficiency syndrome	2.91e-05	0.000341	CcSEcCtD
Clarithromycin—CYP2C19—digestive system—acquired immunodeficiency syndrome	2.91e-05	0.0368	CbGeAlD
Clarithromycin—Headache—Zidovudine—acquired immunodeficiency syndrome	2.9e-05	0.00034	CcSEcCtD
Clarithromycin—Pruritus—Efavirenz—acquired immunodeficiency syndrome	2.88e-05	0.000337	CcSEcCtD
Clarithromycin—Decreased appetite—Lamivudine—acquired immunodeficiency syndrome	2.87e-05	0.000336	CcSEcCtD
Clarithromycin—Hypersensitivity—Delavirdine—acquired immunodeficiency syndrome	2.87e-05	0.000336	CcSEcCtD
Clarithromycin—Urticaria—Ritonavir—acquired immunodeficiency syndrome	2.86e-05	0.000335	CcSEcCtD
Clarithromycin—Feeling abnormal—Saquinavir—acquired immunodeficiency syndrome	2.86e-05	0.000334	CcSEcCtD
Clarithromycin—Gastrointestinal disorder—Lamivudine—acquired immunodeficiency syndrome	2.85e-05	0.000334	CcSEcCtD
Clarithromycin—Fatigue—Lamivudine—acquired immunodeficiency syndrome	2.85e-05	0.000334	CcSEcCtD
Clarithromycin—Dizziness—Indinavir—acquired immunodeficiency syndrome	2.85e-05	0.000333	CcSEcCtD
Clarithromycin—Body temperature increased—Ritonavir—acquired immunodeficiency syndrome	2.85e-05	0.000333	CcSEcCtD
Clarithromycin—Abdominal pain—Ritonavir—acquired immunodeficiency syndrome	2.85e-05	0.000333	CcSEcCtD
Clarithromycin—Gastrointestinal pain—Saquinavir—acquired immunodeficiency syndrome	2.83e-05	0.000332	CcSEcCtD
Clarithromycin—Pain—Lamivudine—acquired immunodeficiency syndrome	2.83e-05	0.000331	CcSEcCtD
Clarithromycin—Constipation—Lamivudine—acquired immunodeficiency syndrome	2.83e-05	0.000331	CcSEcCtD
Clarithromycin—Asthenia—Delavirdine—acquired immunodeficiency syndrome	2.79e-05	0.000327	CcSEcCtD
Clarithromycin—Diarrhoea—Efavirenz—acquired immunodeficiency syndrome	2.78e-05	0.000326	CcSEcCtD
Clarithromycin—CYP2C19—blood—acquired immunodeficiency syndrome	2.77e-05	0.035	CbGeAlD
Clarithromycin—Pruritus—Delavirdine—acquired immunodeficiency syndrome	2.75e-05	0.000323	CcSEcCtD
Clarithromycin—Urticaria—Saquinavir—acquired immunodeficiency syndrome	2.75e-05	0.000322	CcSEcCtD
Clarithromycin—Nausea—Zidovudine—acquired immunodeficiency syndrome	2.75e-05	0.000322	CcSEcCtD
Clarithromycin—Abdominal pain—Saquinavir—acquired immunodeficiency syndrome	2.74e-05	0.000321	CcSEcCtD
Clarithromycin—Body temperature increased—Saquinavir—acquired immunodeficiency syndrome	2.74e-05	0.000321	CcSEcCtD
Clarithromycin—Vomiting—Indinavir—acquired immunodeficiency syndrome	2.74e-05	0.000321	CcSEcCtD
Clarithromycin—Feeling abnormal—Lamivudine—acquired immunodeficiency syndrome	2.72e-05	0.000319	CcSEcCtD
Clarithromycin—Rash—Indinavir—acquired immunodeficiency syndrome	2.71e-05	0.000318	CcSEcCtD
Clarithromycin—Dermatitis—Indinavir—acquired immunodeficiency syndrome	2.71e-05	0.000318	CcSEcCtD
Clarithromycin—Gastrointestinal pain—Lamivudine—acquired immunodeficiency syndrome	2.7e-05	0.000317	CcSEcCtD
Clarithromycin—Headache—Indinavir—acquired immunodeficiency syndrome	2.7e-05	0.000316	CcSEcCtD
Clarithromycin—Dizziness—Efavirenz—acquired immunodeficiency syndrome	2.69e-05	0.000315	CcSEcCtD
Clarithromycin—Diarrhoea—Delavirdine—acquired immunodeficiency syndrome	2.66e-05	0.000312	CcSEcCtD
Clarithromycin—Hypersensitivity—Ritonavir—acquired immunodeficiency syndrome	2.65e-05	0.000311	CcSEcCtD
Clarithromycin—Urticaria—Lamivudine—acquired immunodeficiency syndrome	2.63e-05	0.000307	CcSEcCtD
Clarithromycin—Body temperature increased—Lamivudine—acquired immunodeficiency syndrome	2.61e-05	0.000306	CcSEcCtD
Clarithromycin—Abdominal pain—Lamivudine—acquired immunodeficiency syndrome	2.61e-05	0.000306	CcSEcCtD
Clarithromycin—Vomiting—Efavirenz—acquired immunodeficiency syndrome	2.59e-05	0.000303	CcSEcCtD
Clarithromycin—Asthenia—Ritonavir—acquired immunodeficiency syndrome	2.58e-05	0.000302	CcSEcCtD
Clarithromycin—Dizziness—Delavirdine—acquired immunodeficiency syndrome	2.57e-05	0.000301	CcSEcCtD
Clarithromycin—CYP2C19—vagina—acquired immunodeficiency syndrome	2.57e-05	0.0325	CbGeAlD
Clarithromycin—Rash—Efavirenz—acquired immunodeficiency syndrome	2.57e-05	0.0003	CcSEcCtD
Clarithromycin—Dermatitis—Efavirenz—acquired immunodeficiency syndrome	2.56e-05	0.0003	CcSEcCtD
Clarithromycin—Nausea—Indinavir—acquired immunodeficiency syndrome	2.56e-05	0.0003	CcSEcCtD
Clarithromycin—Hypersensitivity—Saquinavir—acquired immunodeficiency syndrome	2.55e-05	0.000299	CcSEcCtD
Clarithromycin—Headache—Efavirenz—acquired immunodeficiency syndrome	2.55e-05	0.000298	CcSEcCtD
Clarithromycin—Pruritus—Ritonavir—acquired immunodeficiency syndrome	2.55e-05	0.000298	CcSEcCtD
Clarithromycin—Asthenia—Saquinavir—acquired immunodeficiency syndrome	2.49e-05	0.000291	CcSEcCtD
Clarithromycin—Vomiting—Delavirdine—acquired immunodeficiency syndrome	2.47e-05	0.00029	CcSEcCtD
Clarithromycin—Diarrhoea—Ritonavir—acquired immunodeficiency syndrome	2.46e-05	0.000288	CcSEcCtD
Clarithromycin—Rash—Delavirdine—acquired immunodeficiency syndrome	2.45e-05	0.000287	CcSEcCtD
Clarithromycin—Dermatitis—Delavirdine—acquired immunodeficiency syndrome	2.45e-05	0.000287	CcSEcCtD
Clarithromycin—Pruritus—Saquinavir—acquired immunodeficiency syndrome	2.45e-05	0.000287	CcSEcCtD
Clarithromycin—Headache—Delavirdine—acquired immunodeficiency syndrome	2.44e-05	0.000286	CcSEcCtD
Clarithromycin—Hypersensitivity—Lamivudine—acquired immunodeficiency syndrome	2.44e-05	0.000285	CcSEcCtD
Clarithromycin—Nausea—Efavirenz—acquired immunodeficiency syndrome	2.42e-05	0.000283	CcSEcCtD
Clarithromycin—Dizziness—Ritonavir—acquired immunodeficiency syndrome	2.38e-05	0.000279	CcSEcCtD
Clarithromycin—CYP1A2—digestive system—acquired immunodeficiency syndrome	2.38e-05	0.03	CbGeAlD
Clarithromycin—Asthenia—Lamivudine—acquired immunodeficiency syndrome	2.37e-05	0.000278	CcSEcCtD
Clarithromycin—Diarrhoea—Saquinavir—acquired immunodeficiency syndrome	2.37e-05	0.000278	CcSEcCtD
Clarithromycin—Pruritus—Lamivudine—acquired immunodeficiency syndrome	2.34e-05	0.000274	CcSEcCtD
Clarithromycin—Nausea—Delavirdine—acquired immunodeficiency syndrome	2.31e-05	0.000271	CcSEcCtD
Clarithromycin—CYP3A5—digestive system—acquired immunodeficiency syndrome	2.29e-05	0.029	CbGeAlD
Clarithromycin—Dizziness—Saquinavir—acquired immunodeficiency syndrome	2.29e-05	0.000268	CcSEcCtD
Clarithromycin—Vomiting—Ritonavir—acquired immunodeficiency syndrome	2.29e-05	0.000268	CcSEcCtD
Clarithromycin—Rash—Ritonavir—acquired immunodeficiency syndrome	2.27e-05	0.000266	CcSEcCtD
Clarithromycin—Dermatitis—Ritonavir—acquired immunodeficiency syndrome	2.27e-05	0.000266	CcSEcCtD
Clarithromycin—CYP1A2—blood—acquired immunodeficiency syndrome	2.26e-05	0.0286	CbGeAlD
Clarithromycin—Diarrhoea—Lamivudine—acquired immunodeficiency syndrome	2.26e-05	0.000265	CcSEcCtD
Clarithromycin—Headache—Ritonavir—acquired immunodeficiency syndrome	2.26e-05	0.000264	CcSEcCtD
Clarithromycin—Vomiting—Saquinavir—acquired immunodeficiency syndrome	2.2e-05	0.000258	CcSEcCtD
Clarithromycin—Dizziness—Lamivudine—acquired immunodeficiency syndrome	2.19e-05	0.000256	CcSEcCtD
Clarithromycin—Rash—Saquinavir—acquired immunodeficiency syndrome	2.18e-05	0.000256	CcSEcCtD
Clarithromycin—CYP3A5—blood—acquired immunodeficiency syndrome	2.18e-05	0.0276	CbGeAlD
Clarithromycin—Dermatitis—Saquinavir—acquired immunodeficiency syndrome	2.18e-05	0.000256	CcSEcCtD
Clarithromycin—Headache—Saquinavir—acquired immunodeficiency syndrome	2.17e-05	0.000254	CcSEcCtD
Clarithromycin—Nausea—Ritonavir—acquired immunodeficiency syndrome	2.14e-05	0.00025	CcSEcCtD
Clarithromycin—Vomiting—Lamivudine—acquired immunodeficiency syndrome	2.1e-05	0.000246	CcSEcCtD
Clarithromycin—Rash—Lamivudine—acquired immunodeficiency syndrome	2.08e-05	0.000244	CcSEcCtD
Clarithromycin—Dermatitis—Lamivudine—acquired immunodeficiency syndrome	2.08e-05	0.000244	CcSEcCtD
Clarithromycin—Headache—Lamivudine—acquired immunodeficiency syndrome	2.07e-05	0.000242	CcSEcCtD
Clarithromycin—Nausea—Saquinavir—acquired immunodeficiency syndrome	2.06e-05	0.000241	CcSEcCtD
Clarithromycin—CYP3A5—vagina—acquired immunodeficiency syndrome	2.02e-05	0.0256	CbGeAlD
Clarithromycin—CYP1A2—lung—acquired immunodeficiency syndrome	1.98e-05	0.0251	CbGeAlD
Clarithromycin—Nausea—Lamivudine—acquired immunodeficiency syndrome	1.96e-05	0.00023	CcSEcCtD
Clarithromycin—CYP3A5—lung—acquired immunodeficiency syndrome	1.91e-05	0.0242	CbGeAlD
Clarithromycin—ABCB1—retina—acquired immunodeficiency syndrome	1.73e-05	0.0219	CbGeAlD
Clarithromycin—CYP3A4—digestive system—acquired immunodeficiency syndrome	1.72e-05	0.0217	CbGeAlD
Clarithromycin—CYP3A4—blood—acquired immunodeficiency syndrome	1.64e-05	0.0207	CbGeAlD
Clarithromycin—CYP3A4—nervous system—acquired immunodeficiency syndrome	1.33e-05	0.0168	CbGeAlD
Clarithromycin—CYP3A4—central nervous system—acquired immunodeficiency syndrome	1.28e-05	0.0162	CbGeAlD
Clarithromycin—ABCB1—lymphoid tissue—acquired immunodeficiency syndrome	1.23e-05	0.0156	CbGeAlD
Clarithromycin—ABCB1—digestive system—acquired immunodeficiency syndrome	1.22e-05	0.0154	CbGeAlD
Clarithromycin—ABCB1—blood—acquired immunodeficiency syndrome	1.16e-05	0.0147	CbGeAlD
Clarithromycin—ABCB1—bone marrow—acquired immunodeficiency syndrome	1.12e-05	0.0142	CbGeAlD
Clarithromycin—ABCB1—spinal cord—acquired immunodeficiency syndrome	1.12e-05	0.0141	CbGeAlD
Clarithromycin—ABCB1—vagina—acquired immunodeficiency syndrome	1.08e-05	0.0136	CbGeAlD
Clarithromycin—ABCB1—lung—acquired immunodeficiency syndrome	1.02e-05	0.0129	CbGeAlD
Clarithromycin—ABCB1—nervous system—acquired immunodeficiency syndrome	9.42e-06	0.0119	CbGeAlD
Clarithromycin—ABCB1—central nervous system—acquired immunodeficiency syndrome	9.07e-06	0.0115	CbGeAlD
Clarithromycin—ABCB1—brain—acquired immunodeficiency syndrome	7.2e-06	0.0091	CbGeAlD
Clarithromycin—ABCB1—lymph node—acquired immunodeficiency syndrome	6.95e-06	0.00879	CbGeAlD
